Hypertension Management in Patients with Chronic Kidney Disease

Sean A. Hebert; Hassan N. Ibrahim

doi:10.14797/mdcvj.1119

Hypertension Management in Patients with Chronic Kidney Disease

Methodist DeBakey Cardiovascular Journal

Volume 18 (2022): Issue 4

By: Sean A. Hebert and Hassan N. Ibrahim

Open Access

|Sep 2022

Collins AJ, Foley RN, Herzog C, et al. US Renal Data System 2010 Annual Data Report. Am J Kidney Dis. 2011 Jan;57(1 Suppl 1):A8, e1-526. doi: 10.1053/j.ajkd.2010.10.007
Open DOI Search in Google Scholar Back to article
Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018 May 15;71(19):e127-e248. doi: 10.1016/j.jacc.2017.11.006
Open DOI Search in Google Scholar Back to article
Drawz PE, Brown R, De Nicola L, et al. Variations in 24-Hour BP Profiles in Cohorts of Patients with Kidney Disease around the World: The I-DARE Study. Clin J Am Soc Nephrol. 2018 Sep 7;13(9):1348-1357. doi: 10.2215/CJN.13181117
Open DOI Search in Google Scholar Back to article
Rahman M, Wang X, Bundy JD, et al. Prognostic Significance of Ambulatory BP Monitoring in CKD: A Report from the Chronic Renal Insufficiency Cohort (CRIC) Study. J Am Soc Nephrol. 2020 Nov;31(11):2609-2621. doi: 10.1681/ASN.2020030236
Open DOI Search in Google Scholar Back to article
Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group. KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. Kidney Int. 2021 Mar;99(3S):S1-S87. doi: 10.1016/j.kint.2020.11.003
Open DOI Search in Google Scholar Back to article
Ahmad FS, Chan C, Rosenman MB, et al. Validity of Cardiovascular Data From Electronic Sources: The Multi-Ethnic Study of Atherosclerosis and HealthLNK. Circulation. 2017 Sep 26;136(13):1207-1216. doi: 10.1161/CIRCULATIONAHA.117.027436
Open DOI Search in Google Scholar Back to article
Drawz PE, Agarwal A, Dwyer JP, et al. Concordance Between Blood Pressure in the Systolic Blood Pressure Intervention Trial and in Routine Clinical Practice. JAMA Intern Med. 2020 Dec 1;180(12):1655-1663. doi: 10.1001/jamainternmed.2020.5028
Open DOI Search in Google Scholar Back to article
Agarwal R. Implications of Blood Pressure Measurement Technique for Implementation of Systolic Blood Pressure Intervention Trial (SPRINT). J Am Heart Assoc. 2017 Feb 3;6(2):e004536. doi: 10.1161/JAHA.116.004536
Open DOI Search in Google Scholar Back to article
Rakotz MK, Townsend RR, Yang J, et al. Medical students and measuring blood pressure: Results from the American Medical Association Blood Pressure Check Challenge. J Clin Hypertens (Greenwich). 2017 Jun;19(6):614-619. doi: 10.1111/jch.13018
Open DOI Search in Google Scholar Back to article
Drevenhorn E, Hakansson A, Petersson K. Blood pressure measurement--an observational study of 21 public health nurses. J Clin Nurs. 2001 Mar;10(2):189-94. doi: 10.1046/j.1365-2702.2001.00481.x
Open DOI Search in Google Scholar Back to article
Hayer R, Kirley K, Cohen JB, et al. Using web-based training to improve accuracy of blood pressure measurement among health care professionals: A randomized trial. J Clin Hypertens (Greenwich). 2022 Mar;24(3):255-262. doi: 10.1111/jch.14419
Open DOI Search in Google Scholar Back to article
Parati G, Stergiou G, O‘Brien E, et al. European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens. 2014 Jul;32(7):1359-66. doi: 10.1097/HJH.0000000000000221
Open DOI Search in Google Scholar Back to article
Mojón A, Ayala DE, Piñeiro L, et al. Comparison of ambulatory blood pressure parameters of hypertensive patients with and without chronic kidney disease. Chronobiol Int. 2013 Mar;30(1-2):145-58. doi: 10.3109/07420528.2012.703083
Open DOI Search in Google Scholar Back to article
Kotchen TA. Historical trends and milestones in hypertension research: a model of the process of translational research. Hypertension. 2011 Oct;58(4):522-38. doi: 10.1161/HYPERTENSIONAHA.111.177766
Open DOI Search in Google Scholar Back to article
Wright JT, Williamson JD, Whelton PK, et al.; SPRINT Research Group. A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med. 2015 Nov 26;373(22):2103-16. doi: 10.1056/NEJMoa1511939
Open DOI Search in Google Scholar Back to article
Greenland P, Peterson E. The New 2017 ACC/AHA Guidelines “Up the Pressure” on Diagnosis and Treatment of Hypertension. JAMA. 2017 Dec 5;318(21):2083-2084. doi: 10.1001/jama.2017.18605
Open DOI Search in Google Scholar Back to article
Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018 Sep 1;39(33):3021-3104. doi: 10.1093/eurheartj/ehy339
Open DOI Search in Google Scholar Back to article
Cheung AK, Rahman M, Reboussin DM, et al. Effects of Intensive BP Control in CKD. J Am Soc Nephrol. 2017 Sep;28(9):2812-2823. doi: 10.1681/ASN.2017020148
Open DOI Search in Google Scholar Back to article
Klahr S, Levey AS, Beck GJ, et al. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med. 1994 Mar 31;330(13):877-84. doi: 10.1056/NEJM199403313301301
Open DOI Search in Google Scholar Back to article
Wright JT Jr, Bakris G, Greene T, et al. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA. 2002 Nov 20;288(19):2421-31. doi: 10.1001/jama.288.19.2421
Open DOI Search in Google Scholar Back to article
Ruggenenti P, Perna A, Loriga G, et al. Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial. Lancet. 2005 Mar 12-18;365(9463):939-46. doi: 10.1016/S0140-6736(05)71082-5
Open DOI Search in Google Scholar Back to article
Malhotra R, Nguyen HA, Benavente O, et al. Association Between More Intensive vs Less Intensive Blood Pressure Lowering and Risk of Mortality in Chronic Kidney Disease Stages 3 to 5: A Systematic Review and Meta-analysis. JAMA Intern Med. 2017 Oct 1;177(10):1498-1505. doi: 10.1001/jamainternmed.2017.4377
Open DOI Search in Google Scholar Back to article
Georgianos PI, Agarwal R. Hypertension in Chronic Kidney Disease (CKD): Diagnosis, Classification, and Therapeutic Targets. Am J Hypertens. 2021 Apr 20;34(4):318-326. doi: 10.1093/ajh/hpaa209
Open DOI Search in Google Scholar Back to article
Agarwal R, Andersen MJ. Prognostic importance of ambulatory blood pressure recordings in patients with chronic kidney disease. Kidney Int. 2006 Apr;69(7):1175-80. doi: 10.1038/sj.ki.5000247
Open DOI Search in Google Scholar Back to article
Agarwal R, Pappas MK, Sinha AD. Masked Uncontrolled Hypertension in CKD. J Am Soc Nephrol. 2016 Mar;27(3):924-32. doi: 10.1681/ASN.2015030243
Open DOI Search in Google Scholar Back to article
Ku E, Hsu RK, Tuot DS, et al. Magnitude of the Difference Between Clinic and Ambulatory Blood Pressures and Risk of Adverse Outcomes in Patients With Chronic Kidney Disease. J Am Heart Assoc. 2019 May 7;8(9):e011013. doi: 10.1161/JAHA.118.011013
Open DOI Search in Google Scholar Back to article
Parati G, Agabiti-Rosei E, Bakris GL, et al. MASked-unconTrolled hypERtension management based on office BP or on ambulatory blood pressure measurement (MASTER) Study: a randomised controlled trial protocol. BMJ Open. 2018 Dec 19;8(12):e021038. doi: 10.1136/bmjopen-2017-021038
Open DOI Search in Google Scholar Back to article
Sacks FM, Svetkey LP, Vollmer WM, et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med. 2001 Jan 4;344(1):3-10. doi: 10.1056/NEJM200101043440101
Open DOI Search in Google Scholar Back to article
Staruschenko A. Beneficial Effects of High Potassium: Contribution of Renal Basolateral K + Channels. Hypertension. 2018 Jun;71(6):1015-1022. doi: 10.1161/HYPERTENSIONAHA.118.10267
Open DOI Search in Google Scholar Back to article
Wright JA, Cavanaugh KL. Dietary sodium in chronic kidney disease: a comprehensive approach. Semin Dial. Jul-Aug 2010;23(4):415-21. doi: 10.1111/j.1525-139X.2010.00752.x
Open DOI Search in Google Scholar Back to article
Flesher M, Woo P, Chiu A, Charlebois A, Warburton DE, Leslie B. Self-management and biomedical outcomes of a cooking, and exercise program for patients with chronic kidney disease. J Ren Nutr. 2011 Mar;21(2):188-95. doi: 10.1053/j.jrn.2010.03.009
Open DOI Search in Google Scholar Back to article
Look AHEAD Research Group. Effect of a long-term behavioural weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: a secondary analysis of the Look AHEAD randomised clinical trial. Lancet Diabetes Endocrinol. 2014 Oct;2(10):801-9. doi: 10.1016/S2213-8587(14)70156-1
Open DOI Search in Google Scholar Back to article
Heiwe S, Jacobson SH. Exercise training in adults with CKD: a systematic review and meta-analysis. Am J Kidney Dis. 2014 Sep;64(3):383-93. doi: 10.1053/j.ajkd.2014.03.020
Open DOI Search in Google Scholar Back to article
Greenwood SA, Koufaki P, Mercer TH, et al. Effect of exercise training on estimated GFR, vascular health, and cardiorespiratory fitness in patients with CKD: a pilot randomized controlled trial. Am J Kidney Dis. 2015 Mar;65(3):425-34. doi: 10.1053/j.ajkd.2014.07.015
Open DOI Search in Google Scholar Back to article
Howden EJ, Coombes JS, Strand H, Douglas B, Campbell KL, Isbel NM. Exercise training in CKD: efficacy, adherence, and safety. Am J Kidney Dis. 2015 Apr;65(4):583-91. doi: 10.1053/j.ajkd.2014.09.017
Open DOI Search in Google Scholar Back to article
Van Craenenbroeck AH, Van Craenenbroeck EM, Van Ackeren K, et al. Effect of Moderate Aerobic Exercise Training on Endothelial Function and Arterial Stiffness in CKD Stages 3-4: A Randomized Controlled Trial. Am J Kidney Dis. 2015 Aug;66(2):285-96. doi: 10.1053/j.ajkd.2015.03.015
Open DOI Search in Google Scholar Back to article
Jones DW, Whelton PK, Allen N, et al. Management of Stage 1 Hypertension in Adults With a Low 10-Year Risk for Cardiovascular Disease: Filling a Guidance Gap: A Scientific Statement From the American Heart Association. Hypertension. 2021 Jun;77(6):e58-e67. doi: 10.1161/HYP.0000000000000195
Open DOI Search in Google Scholar Back to article
Neter JE, Stam BE, Kok FJ, Grobbee DE, Geleijnse JM. Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension. 2003 Nov;42(5):878-84. doi: 10.1161/01.HYP.0000094221.86888.AE
Open DOI Search in Google Scholar Back to article
Pengo MF, Soranna D, Giontella A, et al. Obstructive sleep apnoea treatment and blood pressure: which phenotypes predict a response? A systematic review and meta-analysis. Eur Respir J. 2020 May 7;55(5):1901945. doi: 10.1183/13993003.01945-2019
Open DOI Search in Google Scholar Back to article
Nigam G, Camacho M, Chang ET, Riaz M. Exploring sleep disorders in patients with chronic kidney disease. Nat Sci Sleep. 2018 Jan 31;10:35-43. doi: 10.2147/NSS.S125839
Open DOI Search in Google Scholar Back to article
Wiysonge CS, Bradley HA, Volmink J, Mayosi BM, Opie LH. Beta-blockers for hypertension. Cochrane Database Syst Rev. 2017 Jan 20;1(1):CD002003. doi: 10.1002/14651858.CD002003.pub5
Open DOI Search in Google Scholar Back to article
Nazarzadeh M, Bidel Z, Canoy D, et al. Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysis. Lancet. 2021 Nov 13;398(10313):1803-1810. doi: 10.1016/S0140-6736(21)01920-6
Open DOI Search in Google Scholar Back to article
Sarafidis PA, Khosla N, Bakris GL. Antihypertensive therapy in the presence of proteinuria. Am J Kidney Dis. 2007 Jan;49(1):12-26. doi: 10.1053/j.ajkd.2006.10.014
Open DOI Search in Google Scholar Back to article
Ruggenenti P, Perna A, Benini R, et al. In chronic nephropathies prolonged ACE inhibition can induce remission: dynamics of time-dependent changes in GFR. Investigators of the GISEN Group. Gruppo Italiano Studi Epidemiologici in Nefrologia. J Am Soc Nephrol. 1999 May;10(5):997-1006. doi: 10.1681/ASN.V105997
Open DOI Search in Google Scholar Back to article
Xie X, Liu Y, Perkovic V, et al. Renin-Angiotensin System Inhibitors and Kidney and Cardiovascular Outcomes in Patients With CKD: A Bayesian Network Meta-analysis of Randomized Clinical Trials. Am J Kidney Dis. 2016 May;67(5):728-41. doi: 10.1053/j.ajkd.2015.10.011
Open DOI Search in Google Scholar Back to article
Fried LF, Emanuele N, Zhang JH, et al. Combined angiotensin inhibition for the treatment of diabetic nephropathy. N Engl J Med. 2013 Nov 14;369(20):1892-903. doi: 10.1056/NEJMoa1303154
Open DOI Search in Google Scholar Back to article
Agarwal R, Lewis R, Davis JL, Becker B. Lisinopril therapy for hemodialysis hypertension: hemodynamic and endocrine responses. Am J Kidney Dis. 2001 Dec;38(6):1245-50. doi: 10.1053/ajkd.2001.29221
Open DOI Search in Google Scholar Back to article
Locatelli F, Del Vecchio L, Andrulli S, Colzani S. Role of combination therapy with ACE inhibitors and calcium channel blockers in renal protection. Kidney Int Suppl. 2002 Dec;(82):S53-60. doi: 10.1046/j.1523-1755.62.s82.11.x
Open DOI Search in Google Scholar Back to article
Steuber TD, Lee J, Holloway A, Andrus MR. Nondihydropyridine Calcium Channel Blockers for the Treatment of Proteinuria: A Review of the Literature. Ann Pharmacother. 2019 Oct;53(10):1050-1059. doi: 10.1177/1060028019843644
Open DOI Search in Google Scholar Back to article
Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003 May 21;289(19):2560-72. doi: 10.1001/jama.289.19.2560
Open DOI Search in Google Scholar Back to article
Agarwal R, Sinha AD, Cramer AE, et al. Chlorthalidone for Hypertension in Advanced Chronic Kidney Disease. N Engl J Med. 2021 Dec 30;385(27):2507-2519. doi: 10.1056/NEJMoa2110730
Open DOI Search in Google Scholar Back to article
Ernst ME, Carter BL, Goerdt CJ, et al. Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure. Hypertension. 2006 Mar;47(3):352-8. doi: 10.1161/01.HYP.0000203309.07140.d3
Open DOI Search in Google Scholar Back to article
Chun KH, Lee CJ, Oh J, et al. Prevalence and prognosis of the 2018 vs 2008 AHA definitions of apparent treatment-resistant hypertension in high-risk hypertension patients. J Clin Hypertens (Greenwich). 2020 Nov;22(11):2093-2102. doi: 10.1111/jch.14043
Open DOI Search in Google Scholar Back to article
Chung EY, Ruospo M, Natale P, et al. Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease. Cochrane Database Syst Rev. 2020 Oct 27;10(10):CD007004. doi: 10.1002/14651858.CD007004.pub4
Open DOI Search in Google Scholar Back to article
Agarwal R, Rossignol P, Romero A, et al. Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trial. Lancet. 2019 Oct 26;394(10208):1540-1550. doi: 10.1016/S0140-6736(19)32135-X
Open DOI Search in Google Scholar Back to article
Bakris GL, Agarwal R, Anker SD, et al. Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes. N Engl J Med. 2020 Dec 3;383(23):2219-2229. doi: 10.1056/NEJMoa2025845
Open DOI Search in Google Scholar Back to article
Schmieder RE, Langenfeld MR, Gatzka CD, Weidinger G, Schobel HP. Impact of alpha- versus beta-blockers on hypertensive target organ damage: results of a double-blind, randomized, controlled clinical trial. Am J Hypertens. 1997 Sep;10(9 Pt 1):985-91. doi: 10.1016/s0895-7061(97)00161-1
Open DOI Search in Google Scholar Back to article
Kario K, Okada K, Kato M, et al. 24-Hour Blood Pressure-Lowering Effect of an SGLT-2 Inhibitor in Patients with Diabetes and Uncontrolled Nocturnal Hypertension: Results from the Randomized, Placebo-Controlled SACRA Study. Circulation. 2018 Nov 29;139(18):2089-2097. doi: 10.1161/CIRCULATIONAHA.118.037076
Open DOI Search in Google Scholar Back to article
Ye N, Jardine MJ, Oshima M, et al. Blood Pressure Effects of Canagliflozin and Clinical Outcomes in Type 2 Diabetes and Chronic Kidney Disease: Insights From the CREDENCE Trial. Circulation. 2021 May 4;143(18):1735-1749. doi: 10.1161/CIRCULATIONAHA.120.048740
Open DOI Search in Google Scholar Back to article
Pickering TG. The clinical significance of diurnal blood pressure variations. Dippers and nondippers. Circulation. 1990 Feb;81(2):700-2. doi: 10.1161/01.cir.81.2.700
Open DOI Search in Google Scholar Back to article
Wang C, Ye Y, Liu C, et al. Evening versus morning dosing regimen drug therapy for chronic kidney disease patients with hypertension in blood pressure patterns: a systematic review and meta-analysis. Intern Med J. 2017 Aug;47(8):900-906. doi: 10.1111/imj.13490
Open DOI Search in Google Scholar Back to article
Hermida RC, Crespo JJ, Domínguez-Sardiña M, et al. Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial. Eur Heart J. 2020 Dec 21;41(48):4565-4576. doi: 10.1093/eurheartj/ehz754
Open DOI Search in Google Scholar Back to article
Relates to: ‘Bedtime Hypertension Treatment Improves Cardiovascular Risk Reduction: Hygia Chronotherapy Trial’. Eur Heart J. 2020 Apr 21;41(16):1600. doi: 10.1093/eurheartj/ehaa339
Open DOI Search in Google Scholar Back to article
Burnier M, Kreutz R, Narkiewicz K, Kjeldsen S, Oparil S, Mancia G. Circadian variations in blood pressure and their implications for the administration of antihypertensive drugs: is dosing in the evening better than in the morning? J Hypertens. 2020 Aug;38(8):1396-1406. doi: 10.1097/HJH.0000000000002532
Open DOI Search in Google Scholar Back to article
Choong CL, Wong HS, Lee FY, et al. Dose-Response Relationship Between Diltiazem and Tacrolimus and Its Safety in Renal Transplant Recipients. Transplant Proc. 2018 Oct;50(8):2515-2520. doi: 10.1016/j.transproceed.2018.04.024
Open DOI Search in Google Scholar Back to article
Ibrahim HN, Jackson S, Connaire J, et al. Angiotensin II blockade in kidney transplant recipients. J Am Soc Nephrol. 2013 Feb;24(2):320-7. doi: 10.1681/ASN.2012080777
Open DOI Search in Google Scholar Back to article

Authors

Metrics

Articles in this issue

DOI: https://doi.org/10.14797/mdcvj.1119 | Journal eISSN: 1947-6108

Journal RSS Feed

Language: English

Page range: 41 - 49

Submitted on: Apr 18, 2022

Accepted on: May 3, 2022

Published on: Sep 6, 2022

Published by: Houston Methodist DeBakey Heart & Vascular Center

In partnership with: Paradigm Publishing Services

Keywords:

Hypertension,

Chronic Kidney Disease,

Masked Hypertension,

Ambulatory Blood Pressure Monitor

© 2022 Sean A. Hebert, Hassan N. Ibrahim, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.

Volume 18 (2022): Issue 4